Esquer SM, Valencia CJE

Language: Spanish
References: 13
Page: 209-211
PDF size: 62.90 Kb.

ABSTRACT

Rett’s syndrome (RS) is a pervasive neurodevelopmental disorder characterized by autistic behavior, stereotypic movements of hands, loss speech and communication, acquired microcephaly. The diagnosis of RS is mainly based on their clinical characteristics and evolution of the syndrome, there is no laboratory marker that facilitates diagnosis. RS patients often are confused with autism, although they differ in their evolution. We report a case of the RS diagnosed 3 years 9 months age where was found proliferation of harmful bacteria and yeast and high levels of neurotoxic metals.

REFERENCES

1. Tejada MI. Síndrome de Rett: actualización diagnóstica, clínica y molecular. Rev Neurología 2006; 42(Supl 1): S55-S59.

2. Schwartzman JS, De Souza AM, Faiwichow G, Hercowitz LH. Rett phenotype in patient with XXY karyotype: case report. Arq Neuropsiquiatr 1998; 56(4): 824-8.

3. Schwartzman JS, Bernardino A, Nishimura A, Gomez RR, Zatz M. Rett’s syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 2001; 32(3): 162-4.

4. Sartori S, Di Rosa G, Polli R, Bettella E, Tricomi G, Tortorella G, Murgia A. A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett’s syndrome. Am J Med Genet A 2009; 15:149(2): 232-6.

5. Bienvenu T, Philippe C, De Roux N, Raynaud M, Bonnefond JP, Pasquier L et al. The incidence of Rett’s syndrome in France. Pediatr Neurol 2006; 34(5): 372-5

6. Wong VC, Li SY. Rett’s syndrome: prevalence among chinese and a comparison of MECP2 mutations of classic Rett’s syndrome with other neurodevelopmental disorders. J Child Neurol 2007; 22(12): 1397-400.

7. Temudo T, Maciel P. Síndrome de Rett. Características clínicas y avances genéticos. Rev Neurología 2002; 34(Supl 1): S54-S58.

8. Amir RE, Van Den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett’s syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23(2): 185-8.

9. Shaw W, Kassen E, Chavez E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chemistry 1995; 41: 1094-1104.

10. Bradstreet J, Geier D, Kartzinel J, Adams J, Geier M. A case-control study of mercury burden in children with autistic spectrum disorders. J Amer Phys and Surg 2003; 8(3): 76-9.

11. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev 1998; 3(4): 262-70.

12. Miller A. Dimercaptosuccinic acid (DMSA) a non-toxic water-soluble treatment for heavy metal toxicity. Altern Med Rev 1998; 3(3): 199-207.

13. Williamson S. Rett’s syndrome: New clinical and molecular insights. European Journal of Human Genetics 2006; 14: 896-903.